Abstract
Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is frequently reported in the literature; however, its pathophysiology has not been fully elucidated to date. We herein describe a case of MTX-LPD that occurred after long-term treatment with oral MTX in a 67-year-old Japanese woman with rheumatoid arthritis (RA) who presented with generalized lymphadenopathy of the neck. The patient had been diagnosed with RA 24 years earlier, and had been on oral MTX for 20 years. The patient noticed a mass on her neck, which prompted a visit to our hospital. The mass was confirmed as diffuse large B-cell lymphoma by biopsy. MTX treatment was discontinued, which resulted in a reduction in the size of the mass and improvement of the patient's symptoms. Therefore, clinicians must be aware of MTX-LPD as a differential diagnosis for patients with rheumatological conditions on long-term MTX therapy presenting with signs and symptoms suggestive of lymphoma.
References
May 16, 2002·Blood·Xavier MarietteUNKNOWN Investigators of the Club Rhumatismes et Inflammation
May 27, 2004·Leukemia & Lymphoma·A ZaidiD H Vesole
Mar 2, 2006·Arthritis and Rheumatism·Eva BaecklundLars Klareskog
Jul 27, 2007·American Journal of Hematology·Takuya MiyazakiYoshiaki Ishigatsubo
Sep 22, 2011·Leukemia & Lymphoma·Michihide TokuhiraMasahiro Kizaki
Apr 9, 2013·European Journal of Haematology·Ayako IchikawaKoichi Ohshima
Feb 7, 2014·Modern Rheumatology·Sho MokudaKiyoshi Takasugi
Feb 12, 2014·Arthritis Care & Research·Tomohiro KamedaTakuya Matsunaga
Jan 17, 2015·The Journal of Rheumatology·Atsushi HashimotoShigeto Tohma
Sep 4, 2015·Internal Medicine·Hiroshi UreshinoShinya Kimura
Aug 16, 2016·Internal Medicine·Kazuya IshiguroTadao Ishida
Nov 17, 2016·Modern Rheumatology·Takayuki KatsuyamaJun Wada
Mar 8, 2017·Annals of the Rheumatic Diseases·Josef S SmolenDésirée van der Heijde
Apr 6, 2017·Cancer Science·Yuka GionYasuharu Sato
Jun 2, 2018·Arthritis & Rheumatology·Daniel R LuWilliam H Robinson